We are live on ! Find out more
PODD icon

Insulet

682 hedge funds and large institutions have $18.4B invested in Insulet in 2024 Q4 according to their latest regulatory filings, with 126 funds opening new positions, 248 increasing their positions, 225 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 54

12% more capital invested

Capital invested by funds: $16.5B → $18.4B (+$1.93B)

10% more repeat investments, than reductions

Existing positions increased: 248 | Existing positions reduced: 225

10% more funds holding

Funds holding: 622682 (+60)

0.56% less ownership

Funds ownership: 101.1%100.53% (-0.56%)

31% less call options, than puts

Call options by funds: $123M | Put options by funds: $177M

Holders
682
Holders Change
+60
Holders Change %
+9.65%
% of All Funds
8.98%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
126
Increased
248
Reduced
225
Closed
54
Calls
$123M
Puts
$177M
Net Calls
-$54.3M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$133M -$6.08M -24,161 -5%
Primecap Management
27
Primecap Management
California
$129M -$14.8M -58,880 -11%
Marshall Wace
28
Marshall Wace
United Kingdom
$127M +$28M +111,119 +30%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$117M -$1.99M -7,899 -2%
Amundi
30
Amundi
France
$114M +$1.28M +5,081 +1%
Fisher Asset Management
31
Fisher Asset Management
Washington
$98.6M +$6.7M +26,594 +8%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$92.5M +$25.8M +102,291 +41%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$84.9M -$2.93M -11,624 -3%
BG
34
Bellevue Group
Switzerland
$84M -$25.1M -99,562 -24%
Legal & General Group
35
Legal & General Group
United Kingdom
$83.7M -$6.95M -27,599 -8%
Baird Financial Group
36
Baird Financial Group
Wisconsin
$76.9M -$6.6M -26,192 -8%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$75.6M +$21.8M +86,505 +43%
Deutsche Bank
38
Deutsche Bank
Germany
$71.9M +$13.2M +52,243 +23%
Raymond James Financial
39
Raymond James Financial
Florida
$69.4M +$67M +265,957 New
PA
40
Perceptive Advisors
New York
$60.6M +$22.7M +90,000 +63%
N
41
Nuveen
North Carolina
$59.6M -$4.06M -16,134 -7%
Man Group
42
Man Group
United Kingdom
$57.7M -$29.2M -116,062 -34%
PAMP
43
Polar Asset Management Partners
Ontario, Canada
$56.8M -$1.61M -6,400 -3%
ATO
44
Alecta Tjanstepension Omsesidigt
Sweden
$53.2M +$51.3M +203,800 New
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$52.9M +$187K +744 +0.4%
Swiss National Bank
46
Swiss National Bank
Switzerland
$51.7M -$2.32M -9,200 -4%
Envestnet Asset Management
47
Envestnet Asset Management
Illinois
$49.2M +$6.27M +24,892 +15%
Aberdeen Group
48
Aberdeen Group
United Kingdom
$47.9M -$4.8M -19,046 -9%
William Blair & Company
49
William Blair & Company
Illinois
$47.9M -$1.2M -4,778 -3%
OCBV
50
Ownership Capital B.V.
Netherlands
$47.2M -$3.29M -13,052 -7%

PODD Hedge Fund Activity: Q4 2024 in Review

682 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2024, worth a combined $18.4B — up 12% from $16.5B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new PODD positions and 54 closed out — a net gain of 72 holders — while 248 added to existing stakes and 225 trimmed.

The largest buyer was BlackRock, adding an estimated $70.3M. The largest seller was Goldman Sachs, cutting an estimated $83M.

  • 682 institutional investors held Insulet (PODD) as of Q4 2024, up from 622 in Q3 2024.
  • Funds reported $18.4B of Insulet stock for Q4 2024, up 12% quarter-over-quarter.
  • 126 funds opened new Insulet positions in Q4 2024 and 54 closed out, a net change of +72 holders.
  • The largest Insulet buyer in Q4 2024 was BlackRock, an estimated $70.3M added.
  • The largest Insulet seller in Q4 2024 was Goldman Sachs, an estimated $83M sold.

Based on aggregated 13F filings for Q4 2024.